scispace - formally typeset
M

Michal J. Nagiec

Researcher at Cornell University

Publications -  19
Citations -  1254

Michal J. Nagiec is an academic researcher from Cornell University. The author has contributed to research in topics: Phosphorylation & Kinase. The author has an hindex of 15, co-authored 18 publications receiving 1081 citations. Previous affiliations of Michal J. Nagiec include Houston Methodist Hospital & Baylor College of Medicine.

Papers
More filters
Journal ArticleDOI

Genome Sequence of a Serotype M28 Strain of Group A Streptococcus: Potential New Insights into Puerperal Sepsis and Bacterial Disease Specificity

TL;DR: The genome of a genetically representative strain of serotype M28 strains has genes encoding a novel array of prophage virulence factors, cell-surface proteins, and other molecules likely to contribute to host-pathogen interactions.
Journal ArticleDOI

Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus

TL;DR: A serotype M3 clone significantly underrepresented among necrotizing fasciitis cases has a unique frameshift mutation that truncates MtsR, a transcriptional regulator controlling expression of genes encoding iron-acquisition proteins, which provided unprecedented detail about the molecular anatomy of bacterial strain genotype-patient phenotype relationships.
Journal ArticleDOI

Regulation of Cell Signaling Dynamics by the Protein Kinase-Scaffold Ste5

TL;DR: It is proposed that scaffold proteins serve to modulate the temporal and dose-response behavior of the MAP kinase, and thus help cells respond to a gradient or mate efficiently with distant partners.
Journal ArticleDOI

Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells

TL;DR: A system-wide view of phosphorylation events downstream of SDF-1/CXCR4 signaling in breast CSCs is given, providing a resource for the study of CSC-targeted cancer therapy and identifying several previously unidentified phosphoproteins and signaling pathways in Breast cancer stem cells.